Familial adenomatous polyposis medical therapy: Difference between revisions
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The mainstay of treatment for familial adenomatous polyposis is surgery. However, [[non-steroidal anti-inflammatory drug]]s (NSAIDs) | The mainstay of treatment for familial adenomatous polyposis is surgery. However, [[non-steroidal anti-inflammatory drug]]s (NSAIDs) such as sulindac and celecoxib are recommended to decrease the size and number of colon polyps. | ||
==Medical Therapy== | ==Medical Therapy== |
Revision as of 21:36, 30 January 2018
Familial adenomatous polyposis Microchapters |
Differentiating Familial adenomatous polyposis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Familial adenomatous polyposis medical therapy On the Web |
American Roentgen Ray Society Images of Familial adenomatous polyposis medical therapy |
Directions to Hospitals Treating Familial adenomatous polyposis |
Risk calculators and risk factors for Familial adenomatous polyposis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Mohamad Alkateb, MBBCh [3]
Overview
The mainstay of treatment for familial adenomatous polyposis is surgery. However, non-steroidal anti-inflammatory drugs (NSAIDs) such as sulindac and celecoxib are recommended to decrease the size and number of colon polyps.
Medical Therapy
- The mainstay of treatment for familial adenomatous polyposis is surgery.
- Pharmacologic medical therapies for familial adenomatous polyposis include non-steroidal anti-inflammatory drugs (NSAIDs).[1]
- Preferred regimen (1): Sulindac
- Preferred regimen (2): Celecoxib 400 mg twice daily for 6 months
Note (1): non-steroidal anti-inflammatory drugs (NSAIDs) decrease the size and number of colon polyps.
References
- ↑ King JE, Dozois RR, Lindor NM, Ahlquist DA (2000). "Care of patients and their families with familial adenomatous polyposis". Mayo Clin. Proc. 75 (1): 57–67. doi:10.4065/75.1.57. PMID 10630758.